Otsuka (OTCMKTS:OTSKY) Shares Gap Up – Time to Buy?

Otsuka Holdings Co., Ltd. – Unsponsored ADR (OTCMKTS:OTSKY)’s share price gapped up before the market opened on Friday. The stock had previously closed at $36.05, but opened at $38.50. Otsuka shares last traded at $38.50, with a volume of 20,308 shares traded.

Analyst Upgrades and Downgrades

Separately, Zacks Research upgraded Otsuka from a “hold” rating to a “strong-buy” rating in a research report on Friday, October 9th. One equities research analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating, one has given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, Otsuka presently has a consensus rating of “Moderate Buy”.

Otsuka Stock Performance

The firm has a market capitalization of $41.47 billion, a P/E ratio of 15.50, a price-to-earnings-growth ratio of 2.59 and a beta of 0.09. The company has a current ratio of 2.21, a quick ratio of 1.65 and a debt-to-equity ratio of 0.05. The business’s 50 day simple moving average is $37.32 and its two-hundred day simple moving average is $35.57.

Otsuka (OTCMKTS:OTSKY) last posted its quarterly earnings results on Friday, July 31st. The company reported $0.70 earnings per share for the quarter, topping analysts’ consensus estimates of $0.51 by $0.19. Otsuka had a net margin of 15.50% and a return on equity of 12.86%. The business had revenue of $4.41 billion during the quarter, compared to analyst estimates of $3.95 billion. Otsuka has set its FY 2026 guidance at 2.119-2.119 EPS. Sell-side analysts anticipate that Otsuka Holdings Co., Ltd. – Unsponsored ADR will post 2.23 EPS for the current fiscal year.

About Otsuka

Otsuka Holdings Co, Ltd. is a Japan-based healthcare company that oversees the Otsuka Group’s pharmaceutical, nutraceutical and consumer health businesses. The company’s operations are primarily conducted through subsidiaries, including Otsuka Pharmaceutical Co, Ltd., which researches, develops, manufactures and markets prescription medicines, over-the-counter products and health-related foods.

Otsuka’s pharmaceutical activities focus on areas such as psychiatry, oncology, cardiovascular and renal medicine, and several other specialized therapeutic fields.